ArticleBMJ health & care informatics2025
Development of data-driven clinical pathways: the big data clinical evidence-based pathways.
Article in BMJ health & care informatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study developed clinical evidence-based pathways (CEBPWs) to standardise treatment protocols, align diagnosis-reimbursement criteria, detect upcoding and enable early overtreatment warnings.
methodsThe CEBPWs were developed based on hospitalised patient-level data from 1 January 2022 to 31 June 2024 in 166 public hospitals in 16 administrative districts of Shanghai. It includes a total of 5 319 336 cases, involving 3 688 108 groups of 'diagnosis+therapy'. 2.61 billion records of hospitalisation charges and 876.45 million records of outpatient charges were collected. GROWTH algorithm was used to find the combination of frequently charged items for examination, treatment, drugs and devices in 'diagnosis+therapy' group.
resultsCEBPWs comprise five key elements: objective evidence identification, accurate classification, value weighting, frequency weighting and temporal sequencing of evidence. We applied CEBPWs to 224 diseases, detecting issues including upcoding, overtreatment and fragmented care episodes to enhance healthcare quality. CEBPWs achieve 100% coverage in diagnostics, therapy and consumables, with 81.81% drug coverage. The pilot evaluation showed that there were violations in 433 cases, with a frequency deviation of 8.64% and cost deviation of 10.82%, with 8.95% for diagnosis, 9.44% for therapy, 14.81% for drugs and 8.98% for consumables. DISCUSSION: We were developed CEBPWs, breaking the limitations of the clinical pathways is that the experience of clinical experts rather than objective criterion based on the characteristics of big data and lack of diagnostic and therapy standards integrated with payment standards.
conclusionThe results indicate that CEBPW is critical tool for hospital management and regulation, address many drawbacks of clinical pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.